Blockbuster weight loss drugs have been arguably the biggest health story of the last several years — and there are no signs ...

High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

In an unconventional alliance, North Carolina State Treasurer Dale Folwell, a Republican, spoke on Capitol Hill at a ...

Lilly and Novo Nordisk, the maker of Ozempic and Wegovy, have been under pressure to lower the cost of their hugely popular — ...

Novo Nordisk NVO shares have lost 5% in the past three months, which translates to approximately $29 billion in market value, ...

"Weight loss medications are not one size fits all and patients should always discuss options with a trusted medical professional," one expert told Newsweek.

A recent study estimated that Wegovy’s label expansion beyond obesity could push Medicare spending to $145 billion annually, ...

After launching a weight-loss drug based on semaglutide, the active ingredient in Wegovy, Hims added 155,000 users in the ...

The drug companies behind blockbuster weight loss and diabetes treatments have signaled that supply problems could soon be ...

Novo Nordisk, maker of Ozempic and Wegovy, now has a market capitalization of more than ... single-dose vials using a needle ...

Ozempic and Wegovy could slow down ageing and have "far-reaching benefits" beyond what was imagined, researchers have suggested. Multiple studies have found semaglutide - available under the brand ...

More Tennessee companies are covering weight-loss injections in health care benefit plans. This could impact the state's high ...